SPL 1.08% 9.4¢ starpharma holdings limited

Ann: DEP HER2-lutetium outperforms in human breast cancer model, page-27

  1. 3,418 Posts.
    lightbulb Created with Sketch. 810
    If you review this thread’s comments, the enthusiasm was high after this announcement (including the direct quote below). However there has so far been zilch published advancement or deal in the 2 years since.


    ”Starpharma will be an ASX 50 before 2025” ~@antibotter

    At last glance QANTAS were ranked number 49 in the ASX50 with a market capitalisation of around $12 billion.

 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.001(1.08%)
Mkt cap ! $38.81M
Open High Low Value Volume
9.3¢ 9.4¢ 9.3¢ $63.86K 686.6K

Buyers (Bids)

No. Vol. Price($)
3 445602 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 19948 1
View Market Depth
Last trade - 12.13pm 12/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.